Skip to main content

Table 2 Specific concomitant diseases at baseline

From: Effectiveness of combination therapy with nifedipine GITS: a prospective, 12-week observational study (AdADOSE)

  Patients (n = 3430)
Patients with specific concomitant diseases, n (%) 3109 (90.6)
 Dyslipidemia 1417 (41.3)
 Obesity 917 (26.7)
 Fatty liver 917 (26.7)
 Stable angina pectoris 445 (13.0)
 Diabetic neuropathy 396 (11.5)
 Microalbuminuria 275 (8.0)
 Diabetic retinopathy 271 (7.9)
 Myocardial infarction 230 (6.7)
 Renal insufficiency 167 (4.9)
 Peripheral vascular disease 158 (4.6)
 Congestive heart failure 141 (4.1)
 Coronary revascularization 137 (4.0)
 Transient ischemic attack 115 (3.4)
 Cerebrovascular accident 97 (2.8)
Number of concomitant diseases, n (%)a  
 1 622 (18.1)
 2 863 (25.2)
 3 685 (20.0)
 4 442 (12.9)
 5 264 (7.7)
 6 149 (4.3)
 7 82 (2.4)
 8 34 (1.0)
 9 12 (0.3)
 10 5 (0.1)
 >10 8 (0.2)
  1. aCoded according to Medical Dictionary for Regulatory Activities System Organ Class